ProVise Management Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,598
| Closed | -$261K | – | 329 |
|
|
2022
Q1 | $261K | Sell |
1,598
-30
| -2% | -$4.9K | 0.02% | 309 |
|
|
2021
Q4 | $276K | Buy |
1,628
+30
| +2% | +$5.09K | 0.03% | 315 |
|
|
2021
Q3 | $302K | Hold |
1,598
| – | – | 0.03% | 287 |
|
|
2021
Q2 | $271K | Hold |
1,598
| – | – | 0.03% | 316 |
|
|
2021
Q1 | $226K | Buy |
+1,598
| New | +$226K | 0.02% | 316 |
|